Individualized Versus Non-Individualized Resistance Training
Een op maat gemaakte interventie om leeftijdsgebonden achteruitgang in spierkracht en functionele vaardigheden te voorkomen
Preserving functional ability is crucial for healthy aging. Unfortunately, age-related decreases in muscle power often lead to declines in functional ability. As power is the product of force and velocity, decreases in power can originate from changes in muscle force, contraction velocity, or both, varying between individuals. The primary method to prevent functional disability is power-based resistance training. Although training interventions are effective for most older adults, they do not induce substantial improvements in a subset of the population. These inconsistent outcomes may arise from neglecting the observed differences in the force-velocity (F-V) profiles between individuals. Therefore, this study provides a novel approach to resistance exercise, in which exercise dose is tailored according to the individual's F-V profile. The effectiveness of the tailored method will be assessed in a randomized control trial, comparing the effects of an individualized and a non-individualized 12-week training intervention on muscle power parameters and functional ability.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Vlaams-Brabant
-
Leuven, Vlaams-Brabant, België, 3000
- KU Leuven - Department of Movement Sciences
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Community-dwelling adults
- At least 65 years old
Exclusion Criteria:
- Systematic engagement in resistance exercise during the past year
- Unstable cardiovascular disease, neuromuscular disease, acute infection or fever
- Recent surgery
- Lower-extremity injuries
- Low levels of functional ability (i.e., SPPB score ≤ 9)
- Cognitive malfunctioning (i.e., Mini-Mental State Examination < 24)
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Individualized resistance exercise program
Individualized exercise dose. All individuals perform resistance exercises at a load that targets their deficit. Individuals with a velocity deficit train at low loads while individuals with a force deficit train at high loads. |
2x/week, 35-45 min sessions, on leg press machine |
|
Actieve vergelijker: Non-individualized resistance exercise program
Non-individualized exercise dose. All individuals perform resistance exercises at a load that does not target their deficit. Individuals with a velocity deficit train at high loads while individuals with a force deficit train at low loads. |
2x/week, 35-45 min sessions, on leg press machine |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Maximal power (Pmax)
Tijdsspanne: Change from baseline at 6 and 12 weeks
|
Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which the maximal power (Pmax; W) was estimated. |
Change from baseline at 6 and 12 weeks
|
|
Maximal isometric force (F0)
Tijdsspanne: Change from baseline at 6 and 12 weeks
|
Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which maximal isometric force (F0; N) was estimated. |
Change from baseline at 6 and 12 weeks
|
|
Maximal unloaded velocity (V0)
Tijdsspanne: Change from baseline at 6 and 12 weeks
|
Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which maximal unloaded velocity (V0; m/s) was estimated. |
Change from baseline at 6 and 12 weeks
|
|
Force-velocity slope
Tijdsspanne: Change from baseline at 6 and 12 weeks
|
Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which the F-V slope (Ns/m) was derived. |
Change from baseline at 6 and 12 weeks
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Short Physical Performance Battery (SPPB)
Tijdsspanne: Score at baseline
|
Total score on the SPPB (min 0, max 12, higher scores indicate better performance) |
Score at baseline
|
|
Hand grip strength
Tijdsspanne: Change from baseline at 6 and 12 weeks
|
Maximal grip strength (kg) of the dominant hand using an isometric dynamometer adjusted for hand size |
Change from baseline at 6 and 12 weeks
|
|
Maximal gait speed
Tijdsspanne: Change from baseline at 6 and 12 weeks
|
The average time (s) to walk 10m as fast as possible |
Change from baseline at 6 and 12 weeks
|
|
Countermovement jump
Tijdsspanne: Change from baseline at 6 and 12 weeks
|
The jump height (mm) in a countermovement jump |
Change from baseline at 6 and 12 weeks
|
|
Timed up-and-go
Tijdsspanne: Change from baseline at 6 and 12 weeks
|
The time (s) needed to stand up from a chair, walk 3 m, turn, walk back and sit down again as fast as possible |
Change from baseline at 6 and 12 weeks
|
|
5-repetition sit-to-stand time
Tijdsspanne: Change from baseline at 6 and 12 weeks
|
The time (s) needed to complete the 5-repetition sit-to-stand test |
Change from baseline at 6 and 12 weeks
|
|
5-repetition sit-to-stand power
Tijdsspanne: Change from baseline at 6 and 12 weeks
|
The average power (watt) produced during the 5-repetition sit-to-stand test |
Change from baseline at 6 and 12 weeks
|
|
30-second sit-to-stand repetitions
Tijdsspanne: Change from baseline at 6 and 12 weeks
|
The number of repetitions completed during the 30-second sit-to-stand test |
Change from baseline at 6 and 12 weeks
|
|
30-second sit-to-stand power
Tijdsspanne: Change from baseline at 6 and 12 weeks
|
The average power (watt) produced during the 30-second sit-to-stand test |
Change from baseline at 6 and 12 weeks
|
|
Stair ascent time
Tijdsspanne: Change from baseline at 6 and 12 weeks
|
The time (s) needed to ascend a flight of stairs |
Change from baseline at 6 and 12 weeks
|
|
Stair ascent power
Tijdsspanne: Change from baseline at 6 and 12 weeks
|
The average power (Watt) produced during the stair ascent test |
Change from baseline at 6 and 12 weeks
|
|
Exercise adherence
Tijdsspanne: Total adherence over 12-week period
|
Number of sessions attended as a percentage of total sessions planned |
Total adherence over 12-week period
|
|
Absolute training load
Tijdsspanne: Consistently recorded throughout the 12-week intervention
|
The absolute load (kg) used during training sessions |
Consistently recorded throughout the 12-week intervention
|
|
Relative training load
Tijdsspanne: Consistently recorded throughout the 12-week intervention
|
The relative load (%1RM) used during training sessions |
Consistently recorded throughout the 12-week intervention
|
|
Number of repetitions
Tijdsspanne: Consistently recorded throughout the 12-week intervention
|
The number of repetitions (n) completed per set |
Consistently recorded throughout the 12-week intervention
|
|
Highest movement velocity within a set
Tijdsspanne: Consistently recorded throughout the 12-week intervention
|
The velocity (m/s) of the fastest repetition in a set (Vmax) |
Consistently recorded throughout the 12-week intervention
|
|
Lowest movement velocity within a set
Tijdsspanne: Consistently recorded throughout the 12-week intervention
|
The velocity (m/s) of the slowest repetition in a set (Vmin) |
Consistently recorded throughout the 12-week intervention
|
|
Velocity loss
Tijdsspanne: Consistently recorded throughout the 12-week intervention
|
The percentage difference between the highest and lowest movement velocity in a set = ([Vmax - Vmin] / Vmax) × 100 |
Consistently recorded throughout the 12-week intervention
|
|
Set-volume index
Tijdsspanne: Consistently recorded throughout the 12-week intervention
|
The number of repetitions × relative load (%1-RM) per set |
Consistently recorded throughout the 12-week intervention
|
|
Session-volume index
Tijdsspanne: Consistently recorded throughout the 12-week intervention
|
The sum of set volumes per session |
Consistently recorded throughout the 12-week intervention
|
Medewerkers en onderzoekers
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- S68434
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .